Brick & Kyle, Associates Pfizer Inc Transaction History

Brick & Kyle, Associates

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$33.47 - $42.56 $248,414 - $315,880	-7,422 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $235,648 - $276,469	7,422 New	7,422 $269,000
Q4 2019 Jan 22, 2020	SELL	$32.92 - $37.36 $250,224 - $283,973	-7,601 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$32.49 - $42.13 $5,685 - $7,372	-175 Reduced 2.25%	7,601 $283,000
Q2 2019 Jul 17, 2019	SELL	$36.98 - $41.52 $72,887 - $81,835	-1,971 Reduced 20.22%	7,776 $0
Q1 2019 Jun 14, 2019	BUY	$37.5 - $41.2 $30,525 - $33,536	814 Added 9.11%	9,747 $0
Q4 2018 Jun 13, 2019	SELL	$38.47 - $43.86 $6,424 - $7,324	-167 Reduced 1.84%	8,933 $369,000
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $54,186 - $57,767	-1,643 Reduced 15.29%	9,100 $330,000
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $12,540 - $14,548	-393 Reduced 3.53%	10,743 $381,000
Q4 2017 Jan 24, 2018	BUY	$33.26 - $35.29 $4,357 - $4,622	131 Added 1.19%	11,136 $403,000
Q3 2017 Nov 08, 2017	BUY	$31.0 - $34.15 $341,155 - $375,820	11,005	11,005 $393,000

3,228

3.62B

77.1M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Brick & Kyle, Associates, based on Form 13F filings with the SEC.

Stay updated on Brick & Kyle, Associates with notifications on news.